HIPRA, the multinational Animal Health company headquartered in Amer, Spain, has announced that it has reached and agreement with the health authorities allowing the principal hospitals in the province of Girona to make use of its new facilities to help speed up the management and production of tests for the Coronavirus.
The facilities, which were only recently built, will receive samples from hospitals in the region which will then be processed in accordance with international protocols and the strictest biosecurity and biocontainment measures in order to test for SARS-Cov-2, is the virus responsible for Covid-19.
It is estimated that this collaboration will last for 2 or 3 weeks but the company has said it will remain in force for as long as the health authorities need its help in the current health emergency.
A spokesperson from HIPRA commented: “As an Animal Health company, for us it is a duty and an act of responsibility to make use of all the resources that we have in order to help preserve public health in such exceptional times, hence the need to collaborate by giving over our new diagnostic centres.
“This type of real-time diagnosis allows hundreds of samples to be analysed in a few hours, backed up by the automation of the process, so we are convinced that this will be of great help.”
The company is also manufacturing components for the manufacture of medical ventilators by 3D printing which will also be supplied to hospitals in the region.
